-
741
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
742
Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
743
Correction: Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
744
Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8+ T-cell antitumor activity via the non-canonical P53/STING pathway
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
745
Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
746
Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
Published 2021-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
747
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
748
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
749
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
750
Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
751
Modulation of myeloid and T cells in vivo by Bruton’s tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
752
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
Published 2021-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
753
Leveraging mRNA technology for antigen based immuno-oncology therapies
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
754
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
Published 2021-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
755
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes
Published 2024-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
756
Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports
Published 2019-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
757
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
758
CAR T-cell detection scoping review: an essential biomarker in critical need of standardization
Published 2023-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
759
CD4 T cell depletion increases memory differentiation of endogenous and CAR T cells and enhances the efficacy of Super2 and IL-33-armored CAR T cells against solid tumors
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
760
Pembrolizumab hybrid dosing is non-inferior to flat dosing in advanced non-small cell lung cancer: a real-world, retrospective bicenter cohort study
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article